戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nitive therapeutic options for patients with hyper IgM syndrome.
2  detection and carrier detection in X-linked hyper IgM syndrome.
3 and are responsible for the X-linked form of hyper IgM syndrome.
4 ion that is absent in patients with X-linked hyper-IgM syndrome.
5 cy, immunoglobulin A deficiency, or X-linked hyper-IgM syndrome.
6  variants with truncated E5 in patients with hyper-IgM syndrome 2 and establish that AID, through the
7 d clinical feature of patients with X-linked hyper-IgM syndrome, an inherited immune deficiency disor
8 unistic infections in patients with X-linked hyper IgM syndrome and in patients with human immunodefi
9 ibed to cause atypical SCID, Omenn syndrome, Hyper IgM syndrome and inflammatory bowel disease-all wi
10 ed primary immunodeficiency characterized by hyper-IgM syndrome and hypohydrotic ectodermal dysplasia
11 hese findings now explain cases of autosomal hyper-IgM syndrome and reveal that critical components f
12 inguish X-linked disease from other forms of hyper IgM syndrome have been reported, nor are there tes
13 -linked anhidrotic ectodermal dysplasia with hyper-IgM syndrome (HED-ID) who have deficient expressio
14 cells from a patient (pt1) with non-X-linked hyper-IgM syndrome (HIGM) possess an atypical CD23(lo) p
15  initiate GC responses, patients with type 1 hyper-IgM syndrome (HIGM1) support populations of IgM(+)
16                                              Hyper-IgM syndrome (HIM) is a rare immunodeficiency diso
17                  With genetic defects in the hyper IgM syndrome identified, it is possible to diagnos
18         To establish the underlying cause of hyper-IgM syndrome in one female patient, B cell functio
19                                          The hyper IgM syndrome is a rare, inherited immune deficienc
20                                     X-linked hyper-IgM syndrome is a rare immunodeficiency disorder r
21 ited deficiency of the CD40 ligand (X-linked hyper-IgM syndrome) is characterized by failure of immun
22                                              Hyper-IgM syndromes result from mutations in CD40 ligand
23 ts with common variable immunodeficiency and hyper IgM syndrome, suggests a potential narrow target f
24                                     Although hyper-IgM syndrome type 2 is rare, the 23 missense mutat
25                                              Hyper-IgM syndrome type 2 stems from mutations in activa
26 duced by bacterial products in patients with hyper-IgM syndrome who lack CD40 ligand expression and i
27 ical autoimmune complications; patients with hyper-IgM syndromes who are deficient in activation-indu
28 ne cases of X-linked hyper-immunoglobulin M (hyper-IgM) syndrome who, due to a mutation in CD40 ligan
29 aB essential modulator (NEMO) cause X-linked hyper-IgM syndrome with ectodermal dysplasia (XHM-ED).
30                       Patients with X-linked hyper-IgM syndrome (X-HIGM) due to CD40 ligand (CD40L) m
31                       Subjects with X-linked hyper-IgM syndrome (X-HIgM) have a markedly reduced freq
32                                     X-linked hyper-IgM syndrome (XHIGM) is a primary immunodeficiency
33                                     X-linked hyper IgM syndrome (XHIM) is a primary immunodeficiency
34                                 The X-linked hyper-IgM syndrome (XHIM) is a primary immunodeficiency
35                                     X-linked hyper-IgM syndrome (XHIM) results from mutations in the
36 ated, the clinical consequences are X-linked hyper-IgM syndrome (XHIM), a primary immunodeficiency di
37                 Three patients with X-linked hyper-IgM syndrome (XHIM), who were all asymptomatic unt
38                                     X-linked hyper IgM syndrome (XHM) is a combined immune deficiency

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。